2-mercapto-5-benzimidazolesulfonic acid: used for separation of antibodies; structure in first source
ID Source | ID |
---|---|
PubMed CID | 2738126 |
SCHEMBL ID | 1160168 |
MeSH ID | M0481511 |
Synonym |
---|
AKOS005447827 |
2-sulfanyl-1h-benzimidazole-5-sulfonic acid |
STK376655 |
2-sulfanylidene-1,3-dihydrobenzimidazole-5-sulfonic acid |
BBL002858 |
58089-27-3 |
SCHEMBL1160168 |
DTXSID80372277 |
2,3-dihydro-2-thioxo-1h-benzimidazole-5-sulfonic acid |
2-mercapto-5-benzimidazolesulfonic acid |
VS-01250 |
2-sulfanyl-1h-1,3-benzodiazole-5-sulfonic acid |
2-thioxo-2,3-dihydro-1h-benzo[d]imidazole-5-sulfonic acid |
2-mercapto-5 benzimidazolesulfonic acid |
CS-0358946 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.84) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |